Daniel Elias Martin Herranz
Chief Science Officer | Biomarker R&D | IVDs | Epigenetics of Ageing | Computational Biology
Dani did his undergrad in Biotechnology at the University of Salamanca (Spain) and his PhD in Computational Biology at the University of Cambridge / EBI (UK).
During the PhD, he had the pleasure to work on the molecular mechanisms of the epigenetic ageing clock with Professor Dame Janet Thornton and Professor Wolf Reik. Driven by the need to make diagnostic technologies more actionable and accessible, he co-founded Hurdle.
As Chief Science Officer at Hurdle, Dani has led the development of novel diagnostics, including the first NGS saliva-based epigenetic clock, the first CE-marked saliva-based COVID PCR test and the first saliva-based epigenetic biomarker for chronic inflammation. At Hurdle, Dani works closely with Biotech and Pharma companies as part of their biomarker strategy, from consumer and digital health applications to companion diagnostics.
Dani is passionate about democratising access to the latest biomarker technologies to ensure the healthy ageing of our societies.
Hire Daniel On-Demand
LifeForce offers 15 Minute to 2 hour consultation sessions you can book with experts right from their calendars.
Book an appointment.
Submit your requirements for an expert through our application form here.
Our LifeForce team will revive your needs and connect you with your expert to have your 15 minute free chat.